Charles River Laboratories International, Inc. (CRL) — Stock Analysis & Fair Value

Charles River Laboratories International, Inc. (CRL) trades on NYSE at $288.50 (US). Market cap $13.90B. P/E -59.6. P/B 4.9. ROE -7.7%. dividend yield 0.0%. 52-week range $144.26–$303.31.

Sector: Healthcare — Medical - Diagnostics & Research.

On getValue you can run 9 valuation models on CRL — DCF, Reverse DCF, Dividend Discount Model (DDM), Cash Flow + IRR, Normalized P/E, Industry Multiple, Piotroski F-Score and NAV — alongside a WACC calculator, up to 10 years of income statement, balance sheet and cash-flow data, peer comparison and insights.

Open the full CRL analysis · Key metrics & insights

getValue is an analysis tool for education, not investment advice. Figures are shown as reported; model outputs depend on your assumptions.